Global cancer statistics: A healthy population relies on population health

Natia Jokhadze¹, Arunangshu Das², Don S Dizon^{3

4}

Affiliations

¹ Clinical Oncology Department, American Hospital Tbilisi, Tbilisi, Georgia.
² Oncology, Square Hospitals Ltd., Dhaka, Bangladesh.
³ Department of Medicine, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
⁴ Department of Medicine, Division of Hematology and Oncology, Lifespan Cancer Institute and Legorreta Cancer Center at Brown University, Providence, Rhode Island, USA.

Free article

Editorial

Natia Jokhadze et al. CA Cancer J Clin. 2024 May-Jun.

Free article

. 2024 May-Jun;74(3):224-226.

doi: 10.3322/caac.21838. Epub 2024 Apr 4.

Natia Jokhadze¹, Arunangshu Das², Don S Dizon^{3

4}

¹ Clinical Oncology Department, American Hospital Tbilisi, Tbilisi, Georgia.
² Oncology, Square Hospitals Ltd., Dhaka, Bangladesh.
³ Department of Medicine, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
⁴ Department of Medicine, Division of Hematology and Oncology, Lifespan Cancer Institute and Legorreta Cancer Center at Brown University, Providence, Rhode Island, USA.

No abstract available

References

1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024:1‐35. doi:10.3322/caac.21834
1. Cancer incidence in five continents. Volume IX. IARC Sci Publ.2008;160:1‐837.
1. Khetsuriani N, Gamkrelidze A, Shadaker S, et al. Toward reaching hepatitis B goals: hepatitis B epidemiology and the impact of two decades of vaccination, Georgia, 2021. Euro Surveill. 2023;28(30):2200837. doi:10.2807/1560‐7917.es.2023.28.30.2200837
1. Shih YCT, Pan IW, Teich N. Global challenges in access to and implementation of precision oncology: the health care manager and health economist perspective. Am Soc Clin Oncol Educ Book. 2022;42:429‐437. doi:10.1200/edbk_359650
1. Jalali R, Nogueira‐Rodrigues A, Das A, Sirohi B, Panda PK. Drug development in low‐ and middle‐income countries: opportunity or exploitation? Am Soc Clin Oncol Educ Book. 2022;42:1‐8. doi:10.1200/edbk_10033